Tuberculosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with secondary pulmonary tuberculosis and secondary pulmonary tuberculosis complicated by extrapulmonary tuberculosis dissemination (tuberculous pleurisy and extrapulmonary tuberculosis) that meet the requirements of the "WS 288-2017 Diagnosis of Pulmonary Tuberculosis". (2) Newly diagnosed patients who have not received anti-tuberculosis drug treatment before. (3) Patients who have signed the ‘Consent Form for the Use of Medical Information and Inpatient Samples for Scientific Research at the Fujian Provincial Tuberculosis Prevention and Treatment Hospital’.
Exclusion criteria
Exclusion criteria: (1) Patients with concurrent HIV infection or viral hepatitis; (2) Patients with concurrent endocrine and metabolic diseases such as diabetes, hyperthyroidism; (3) Patients with concurrent rheumatic diseases: systemic lupus erythematosus; (4) Patients with cancer or taking immunosuppressive drugs; (5) Patients with other concurrent extrapulmonary infections, chronic obstructive pulmonary disease, asthma, bronchiectasis; (6) Pregnant women or lactating women; (7) Patients with sputum or bronchoalveolar lavage fluid culture positive for non-tuberculous mycobacteria; (8) Patients who have used anti-tuberculosis drugs irrationally or irregularly for more than 1 month due to tuberculosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune cell surface markers; | — |
Countries
China
Contacts
Fuzhou Pulmonary Hospital of Fujian, Fuzhou city, Fujian Province(Fujian Provincial Tuberculosis Prevention and Treatment Hospital)